Theracos IPO

theracos.com

Theracos develops, acquires, and supports research programs in inflammation, metabolism, and depression through research activities throughout the world and establishes the clinical efficacy of its therapeutic candidates through multicenter international trials

Founded2000
Total Funding to Date$135.86MM
Register for Details

For more details on financing and valuation for Theracos, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

By registering, you agree to the Forge Terms of Use. Already registered? Click here to log in

Theracos Ticker Symbol

Theracos does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

Theracos Stock Price

The stock price for Theracos will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Theracos Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
9/20/2013 Series C $327.39MM $XXX.XX $XXX.XX
3/29/2011 Series B $123.09MM $XXX.XX $XXX.XX
6/4/2002 Series A $11.08MM $XXX.XX $XXX.XX
Based on primary financings

Other companies like Theracos in the Healthcare sector

Sector
Last Round Est. Valuation
$3.6B
Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$150MM
Sector
Last Round Est. Valuation
$4.8B
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$296.3MM